Literature DB >> 9491942

Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease.

M P McDonald1, J B Overmier.   

Abstract

This paper reviews the current literature on animal models of the memory impairments of Alzheimer's disease (AD). The authors suggest that modeling of the mnemonic deficits in AD be limited to the amnesia observed early in the course of the disease, to eliminate the influence of impairments in non-mnemonic processes. Tasks should be chosen for their specificity and selectivity to the behavioral phenomena observed in early-stage AD and not for their relevance to hypothetical mnemonic processes. Tasks that manipulate the delay between learning and remembering are better able to differentiate Alzheimer patients from persons with other disorders, and better able to differentiate effects of manipulations in animals. The most commonly used manipulations that attempt to model the amnesia of AD are reviewed within these constraints. The authors conclude that of the models examined, lesions of the medial septal nucleus produce behavioral deficits that are most similar to the mnemonic impairments in the earliest stage of AD. However, the parallel is not definitive and more work is needed to clarify the relationship between neurobiology and behavior in AD.

Entities:  

Mesh:

Year:  1998        PMID: 9491942     DOI: 10.1016/s0149-7634(97)00024-9

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  19 in total

1.  Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo.

Authors:  V V Trubetskaya; M Yu Stepanichev; M V Onufriev; N A Lazareva; V A Markevich; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2003-02

2.  Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment.

Authors:  Brandon A Ally; Erin P Hussey; Philip C Ko; Robert J Molitor
Journal:  Hippocampus       Date:  2013-08-14       Impact factor: 3.899

3.  Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze.

Authors:  M Yu Stepanichev; Yu V Moiseeva; N A Lazareva; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2005-06

Review 4.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

5.  Studies of the effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the Hippocampus and impairment of spatial memory.

Authors:  M Yu Stepanichev; I M Zdobnova; I I Zarubenko; N A Lazareva; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2006-01

6.  Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.

Authors:  T J Flanigan; Y Xue; S Kishan Rao; A Dhanushkodi; M P McDonald
Journal:  Genes Brain Behav       Date:  2014-04-22       Impact factor: 3.449

7.  Single intracerebroventricular injection of botulinum toxin type A produces slow onset and long-term memory impairment in rats.

Authors:  Zdravko Lacković; Veseljka Rebić; Peter F Riederer
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

Review 8.  Memory deficits in Alzheimer's disease: the encoding hypothesis and cholinergic function.

Authors:  K Geoffrey White; Angela C Ruske
Journal:  Psychon Bull Rev       Date:  2002-09

9.  Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks.

Authors:  F E Harrison; A H Hosseini; M P McDonald
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

Review 10.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.